Spontaneous baroreflex sensitivity in subjects with type 1 diabetes with and without cardiovascular autonomic neuropathy

Endokrynologia Polska

Volumn 59, Issue 5, 2008, Pages 398-402

  Kamińska, Anna ^a   Tafil Klawe, Małgorzata ^a   Śmietanowski, Maciej ^b   Bronisz, Agata ^a   Ruprecht, Zofia ^a   Klawe, Jacek ^a   Junik, Roman ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Baroreflex sensitivity; Cardiovascular autonomic neuropathy; Diabetes type 1

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE; BODY MASS; BREATHING RATE; CARDIOVASCULAR AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATIENT MONITORING; PRESSORECEPTOR REFLEX;

ADULT; BAROREFLEX; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; SENSITIVITY AND SPECIFICITY;

EID: 57649143864     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Vinik AI, Maser RE, Mitchell BD et al. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579.
2. Kempler P, Tesfaye S, Chaturvedi N et al. Blood pressure response to standing in the diagnosis neuropathy: The EURODIAB IDDM Complications Study Arch Physiol Biochem 2001; 109: 215-222.
3. Orchard TJ, Lloyd CE, Maser RE et al. Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburg Epidemiology of Diabetes Complications Study Diab Res Clin Pract 1996; 34: S165-S171.
4. Veglio M, Sivieri R, Chinaglia A et al. QT interval prolongation and mortality in type 1 diabetic patients. A 5-year cohort prospective study. Diabetes Care 2000; 23: 1381-1383.
5. Maser ER, Mitchell BD, Vinik AI et al. The association between cardiovascular autonomic neuropathy in individuals with diabetes. A meta-analysis. Diabetes Care 2003; 26: 1895-1901.
6. Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabet Metab Rev 1994; 10: 339-383.
7. Kempler P. Autonomic neuropathy: a marker of cardiovascular risk. Br J Diabetes Vasc Dis 2003; 3: 84-90.
8. Ewing DJ, Martyn CN, Young RJ et al. The value of cardiovascular autonomic tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491-498
9. American Diabetes Association and American Academy of Neurology. Consensus statement. Report and recommendations of the San Antonio Conference in diabetic neuropathy. Diabetes 1988; 37: 1000-1004.
10. Boulton AJM, Vinik AJ, Arezzo JC et al. Diabetic Neuropathies. A statement by the American Diabetes Association. Diabetes Care 2005; 28:956-962.
11. Bellavere F, Balzani I, de Masi G et al. Power spectral analysis of heart rate variations improves assessment of diabetic autonomic neuropathy. Diabetes 1992; 41: 633-640.
12. Lagi A, Cipriani M, Pagetti C et al. Power spectrum analysis of heart rate variations in the early detection of diabetic autonomic neuropathy. Clin Autonom Res 1994; 4: 245-248.
13. Howorka K, Pumprla J, Schabmann A. Optimal parameters for short-term heart rate spectrogram for routine evaluation of diabetic cardiovascular autonomic neuropathy. J Auton Nerv Syst 1998; 69: 164-172.
14. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitive method for assesing baroreflex sensitivity. Circ Res 1969; 24: 109-121.
15. Frattola A, Parati G, Gamba P et al. Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia 1997; 40: 1470-1475.
16. Weston PJ, James MA, Panerai RB et al. Evidence of defective cardiovascular regulation in insulin-dependent diabetic patients without clinical autonomic dysfunction. Diab Res Clin Pract 1998; 42: 141-148.
17. Lefrandt JD, Hoogenberg K, van Roon AM et al. Baroreflex sensitivity is depressed in microalbuminuric type 1 diabetic patients at rest and during sympathetic manoeuvres. Diabetologia 1999; 42: 1345-1349.
18. Ducher M, Bertram D, Sagnol I et al. Limits of clinical testes to screen autonomic function in diabetes type 1. Diabetes Metab 2001; 27: 545-550.
19. Imholz BP, Wieling W, van Montfrans GA et al. Fifteen years experience with finger arterial pressure monitoring: assessment of the technology. Cardiovasc Res 1998; 38: 605-616.
20. Schmidt TFH, Wittenhaus J, Steinmetz TF et al. Twenty-four-hour ambulatory noninvasive continuous finger blood pressure measurement with PORTAPRES: a new tool in cardiovascular research. J Cardiovasc Pharmacol 1992; 19: S117-S145.
21. Parati G, Castiglioni P, Di Rienzo M et al. Sequential spectral analysis of 24-hour blood pressure and pulse interval in humans. Hypertension 1990; 16: 414-421.
22. Malliani A, Pagani M, Lombardi F et al. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-492.
23. Skrapari I, Tentolouris N, Katsilambros N. Baroreflex function: determinants in healthy subjects and disturbances in diabetes, obesity and metabolic syndrome. Curr Diab Rev 2006; 2: 329-338.
24. Duchen LW, Anjorin A, Watkins PJ et al. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med 1980; 92: 301-303.
25. La Revere MT, Bigger JT Jr, Marcus FI et al. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: 487-484.
26. Gerritsen J, Dekker JM, Ten Voorde BJ et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease. Diabetes Care 2001; 24: 1793-1798.